Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study.
Tombak A, Uçar MA, Akdeniz A, Tiftik EN, Gören Şahin D, Akay OM, Yıldırım M, Nevruz O, Kis C, Gürkan E, Solmaz ŞM, Özcan MA, Yıldırım R, Berber İ, Erkurt MA, Fıratlı Tuğlular T, Tarkun P, Yavaşoğlu İ, Doğu MH, Sarı İ, Merter M, Özcan M, Yıldızhan E, Kaynar L, Mehtap Ö, Uysal A, Şahin F, Salim O, Sungur MA. Tombak A, et al. Among authors: firatli tuglular t. Turk J Haematol. 2016 Dec 1;33(4):273-280. doi: 10.4274/tjh.2015.0203. Epub 2016 Apr 18. Turk J Haematol. 2016. PMID: 27095141 Free PMC article.
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Beköz H, Karadurmuş N, Paydaş S, Türker A, Toptaş T, Fıratlı Tuğlular T, Sönmez M, Gülbaş Z, Tekgündüz E, Kaya AH, Özbalak M, Taştemir N, Kaynar L, Yıldırım R, Karadoğan I, Arat M, Pepedil Tanrıkulu F, Özkocaman V, Abalı H, Turgut M, Kurt Yüksel M, Özcan M, Doğu MH, Kabukçu Hacıoğlu S, Barışta I, Demirkaya M, Köseoğlu FD, Toprak SK, Yılmaz M, Demirkürek HC, Demirkol O, Ferhanoğlu B. Beköz H, et al. Among authors: firatli tuglular t. Ann Oncol. 2017 Oct 1;28(10):2496-2502. doi: 10.1093/annonc/mdx341. Ann Oncol. 2017. PMID: 28961828 Free article.
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group.
Beksac M, Haznedar R, Firatli-Tuglular T, Ozdogu H, Aydogdu I, Konuk N, Sucak G, Kaygusuz I, Karakus S, Kaya E, Ali R, Gulbas Z, Ozet G, Goker H, Undar L. Beksac M, et al. Among authors: firatli tuglular t. Eur J Haematol. 2011 Jan;86(1):16-22. doi: 10.1111/j.1600-0609.2010.01524.x. Epub 2010 Nov 22. Eur J Haematol. 2011. PMID: 20942865 Clinical Trial.
Giant Intracranial Solitary Plasmacytoma.
Kara O, Toptaş T, Atagündüz I, Bozkurt S, Şirikçi Ö, Fıratlı Tuğlular T. Kara O, et al. Among authors: firatli tuglular t. Turk J Haematol. 2017 Dec 1;34(4):352-353. doi: 10.4274/tjh.2016.0199. Epub 2016 Aug 16. Turk J Haematol. 2017. PMID: 27531229 Free PMC article. No abstract available.
Bortezomib in patients with renal impairment.
Kaygusuz I, Toptas T, Aydin F, Uzay A, Firatli-Tuglular T, Bayik M. Kaygusuz I, et al. Among authors: firatli tuglular t. Hematology. 2011 Jul;16(4):200-8. doi: 10.1179/102453311X13025568941880. Hematology. 2011. PMID: 21756535
Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate.
Kaygusuz Atagunduz I, Toptas T, Deniz R, Kara O, Eser A, Sezgin A, Ozgumus T, Gecgel F, Firatli Tuglular T. Kaygusuz Atagunduz I, et al. Among authors: firatli tuglular t. Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):120-125. doi: 10.1016/j.clml.2016.09.006. Epub 2016 Sep 17. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28082113
Newly diagnosed breast cancer in a patient receiving imatinib mesylate.
Kaygusuz-Atagunduz I, Toptas T, Yumuk F, Firatli-Tuglular T, Bayik M. Kaygusuz-Atagunduz I, et al. Among authors: firatli tuglular t. J Cancer Res Ther. 2014 Oct-Dec;10(4):1107-8. doi: 10.4103/0973-1482.146095. J Cancer Res Ther. 2014. PMID: 25579564 Free article.
23 results